PharmacyCodes



Enprofyllinum [INN-Latin] en es it fr

Enprofyllinum [INN-Latin] Brand names, Enprofyllinum [INN-Latin] Analogs

Enprofyllinum [INN-Latin] Brand Names Mixture

  • No information avaliable

Enprofyllinum [INN-Latin] Chemical_Formula

C8H10N4O2

Enprofyllinum [INN-Latin] RX_link

No information avaliable

Enprofyllinum [INN-Latin] fda sheet

Enprofyllinum [INN-Latin] msds (material safety sheet)

Enprofyllinum [INN-Latin] Synthesis Reference

No information avaliable

Enprofyllinum [INN-Latin] Molecular Weight

194.191 g/mol

Enprofyllinum [INN-Latin] Melting Point

287-289 oC

Enprofyllinum [INN-Latin] H2O Solubility

1200 mg/L

Enprofyllinum [INN-Latin] State

Solid

Enprofyllinum [INN-Latin] LogP

0.33

Enprofyllinum [INN-Latin] Dosage Forms

No information avaliable

Enprofyllinum [INN-Latin] Indication

Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Enprofyllinum [INN-Latin] Pharmacology

Enprofylline is a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine. It antagonizes erythrocyte phosphodiesterase, increasing cAMP activity.

Enprofyllinum [INN-Latin] Absorption

Rapidly absorbed from the digestive tract

Enprofyllinum [INN-Latin] side effects and Toxicity

No information avaliable

Enprofyllinum [INN-Latin] Patient Information

No information avaliable

Enprofyllinum [INN-Latin] Organisms Affected

Humans and other mammals